NCT03889574View on ClinicalTrials.gov

Triple Antithrombotic Therapy in Cardiac Patients Requiring Revascularization

CompletedOBSERVATIONAL
Enrollment

84

Participants

Timeline

Start Date

February 26, 2019

Primary Completion Date

June 27, 2019

Study Completion Date

June 27, 2019

Conditions
Cardiac Disease
Trial Locations (1)

75203

Methodist Dallas Medical Center, Dallas

All Listed Sponsors
lead

Methodist Health System

OTHER

NCT03889574 - Triple Antithrombotic Therapy in Cardiac Patients Requiring Revascularization | Biotech Hunter | Biotech Hunter